LCM
MED icon

Laurion Capital Management’s Medifast MED Stock Holding History

Laurion Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,350
Closed -$498K – 854
2021
Q1 		$498K Sell
2,350
-3,000
-56% -$718K ﹤0.01% 590
2020
Q4 		$1.05M Buy
+5,350
New +$945K 0.01% 406
2019
Q1 		– Sell
-6,803
Closed -$850K – 1119
2018
Q4 		$850K Buy
+6,803
New +$1.16M 0.02% 595
2018
Q2 		– Sell
-6,500
Closed -$607K – 1478
2018
Q1 		$607K Sell
6,500
-70,677
-92% -$5.28M ﹤0.01% 971
2017
Q4 		$5.39M Buy
+77,177
New +$5.12M 0.03% 499

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Laurion Capital Management's MED Position: Q2 2021 in Review

Laurion Capital Management sold out of Medifast (MED) in Q2 2021, closing a stake of 2,350 shares — an estimated $498K sold.

Laurion Capital Management first reported a position in MED in Q4 2017 and held it in 5 quarters. The position peaked at $5.39M in Q4 2017. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

  • Laurion Capital Management reported no remaining Medifast position as of Q2 2021 after selling out during the quarter.
  • Laurion Capital Management sold 2,350 Medifast shares in Q2 2021, an estimated $498K.
  • Laurion Capital Management first reported a position in Medifast in Q4 2017 and held it in 5 quarters.
  • Laurion Capital Management's Medifast position peaked at $5.39M in Q4 2017.
  • 301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on Laurion Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.